Evidence map›Paper›PMID 24634498›Full record

ArticleThe Journal of infectious diseases2014

Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits.

Elizabeth Diago-Navarro, Liang Chen, Virginie Passet, Seth Burack, Amaia Ulacia-Hernando, Rosy Priya Kodiyanplakkal, Michael H Levi, Sylvain Brisse, Barry N Kreiswirth, Bettina C Fries

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. A Novel Technique to CharacterizebioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  10. Article
  11. The making of hypervirulent Klebsiella pneumoniae.Journal of clinical laboratory analysis · 2022
    Review
  12. A Comprehensive Genomic Analysis of the EmergentPathogens (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Elizabeth Diago-NavarroDepartment of Medicine Infectious Disease Division Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Liang ChenPublic Health Research Institute Tuberculosis Center, NJMS-Rutgers University, Newark, New Jersey.
Virginie PassetInstitut Pasteur, Microbial Evolutionary Genomics CNRS, UMR3525, Paris, France;
Seth BurackDepartment of Medicine Infectious Disease Division Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Amaia Ulacia-HernandoDepartment of Medicine Infectious Disease Division Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Rosy Priya KodiyanplakkalDepartment of Medicine Infectious Disease Division Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Michael H LeviDepartment of Clinical Microbiology Montefiore Medical Center, Bronx, New York.
Sylvain BrisseInstitut Pasteur, Microbial Evolutionary Genomics CNRS, UMR3525, Paris, France;
Barry N KreiswirthPublic Health Research Institute Tuberculosis Center, NJMS-Rutgers University, Newark, New Jersey.
Bettina C FriesDepartment of Medicine Infectious Disease Division Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Albert Einstein College of Medicine · USMontefiore Medical Center · USRutgers, The State University of New Jersey · USEvolutionary Genomics (United States) · USInstitut Pasteur · FR

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
The molecular basis of the epidemic blaKPC gene KlebsiellaR01AI090155 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KREISWIRTH, BARRY NEAL · 2011 to 2021
$7.2M
Development of antibodies to capsule of carbapenem resistant Klebsiella pneumoniaR21AI114259 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI FRIES, BETTINA · 2015 to 2016
$435k
NIAID NIH HHS 1R01AI090155NIAID NIH HHS R01 AI090155NIAID NIH HHS R21 AI114259NIAID NIH HHS U54 AI057158NIAID NIH HHS U54-AI057158PHS HHS R01-A1059681
6 · The paper itself

Abstract

backgroundNovel therapies are urgently needed to treat carbapenem-resistant Klebsiella pneumoniae (CR-Kp)-mediated infection, which constitute a major health threat in the United States. In order to assess if it is feasible to develop anticapsular antibodies as a potential novel therapy, it is crucial to first systematically characterize capsular polysaccharide (CPS) and virulence traits in these strains.

methodsForty CR-Kp were genotyped by pulsed field gel electrophoresis, multilocus sequence typing (MLST), and molecular capsule typing (C-patterns and wzi sequencing). Their biofilm formation, serum resistance, macrophage-mediated killing, and virulence in Galleria mellonella were compared. MAb (1C9) was generated by co-immunization with 2 CPSs, and cross-reactivity was investigated.

resultsMLST assigned 80% of CR-Kp isolates to the ST258-clone. Molecular capsule typing identified new C-patterns, including C200/wzi-154, which was widely represented and associated with blaKPC-3-bearing strains. Heterogeneity was detected in biofilm formation and macrophage-mediated killing. Differences in serum resistance correlated with virulence in G. mellonella. ST258 strains carrying blaKPC-3 were less virulent than those with blaKPC-2. MAb 1C9 cross-reacted with 58% of CR-Kp CPSs.

conclusionsCR-Kp ST258 strains exhibit variability of virulence-associated traits. Differences were associated with the type of KPC gene and CPS. Identification of cross-reacting anti-CPS mAbs encourages their development as adjunctive therapy.

Indexed as

beta-Lactam ResistanceAgedAged, 80 and overAnimalsAnti-Bacterial AgentsAntibodies, BacterialBacterial CapsulesBiofilmsBlood Bactericidal ActivityCarbapenemsFemaleGenotypeHumansKlebsiella InfectionsKlebsiella pneumoniaeLepidopteraAnti-Bacterial AgentsAntibodies, BacterialCarbapenemsadjuvant therapycarbapenem resistanceKlebsiella pneumoniaevirulence

Identifiers

PMID24634498
PMCPMC4432395
OpenAlexW2106832471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.